Navigation Links
Study of 137 Meniscus Transplant Procedures in Patients with Arthritis is Presented to the Meniscus Transplantation Study Group at the American Academy of Orthopaedic Surgeons Annual Meeting
Date:3/6/2008

Follow-Up Study Supports Biologic Joint Reconstruction Rather Than

Artificial Total Knee Replacement

SAN FRANCISCO, March 6 /PRNewswire/ -- In a report to the meeting of the Meniscus Transplantation Study Group, presented during the 2008 meeting of the American Academy of Orthopaedic Surgeons, Kevin R. Stone, M.D., of the Stone Research Foundation, San Francisco, presented an update on the outcome of 137 patients with arthritis who have undergone allograft replacement procedures of the meniscus since 1997.

In the follow-up study of objective clinical evaluation and imaging of the knee and the patients' subjective evaluation, 111 patients experienced successful outcomes after periods ranging from three months to 10.5 years. The failure rate was 19% with a mean time to failure of 4.79 years.

The allograft replacement procedure replaces the meniscus with a donor allograft. The procedure, which is used to protect the articular cartilage and/or reduce pain, is performed on an outpatient basis and is done arthroscopically and is, therefore, minimally invasive.

"The importance of this study," according to Dr. Stone, "is that it documents that meniscus replacement is an excellent option for some patients facing artificial total knee replacement. It can reduce patient pain and also delay the necessity for total replacement."

"The study also showed," he said, "that meniscal allograft transplantation is a viable treatment option for arthritic patients of all ages."

Among the unexpected study results was the variation in the objective and subjective evaluations of the procedure's success. In some cases, patients reported reduced or no pain when the objective evaluation and imaging seemed to indicate significant arthritis.

"Thus, subjective patient outcomes are critical in evaluating the success of the procedure," said Dr. Stone.

About The Stone Research Foundation

The Stone Research Foundation engages in research, development and education to prevent, treat and reverse arthritis and joint injuries. Its goal is to find minimally invasive biologic joint replacement treatments. It seeks to harness natural healing and regenerative capacities to reconstruct joints damaged by arthritis and injury. The Stone Research Foundation is a non-profit 501( c )3 organization (Tax I.D. # 94-3228007).

For more information, please contact:

Stephanie Stern, Stern & Co. at 212 888-0044


'/>"/>
SOURCE Stone Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New study sheds light on excessive drinking among the elderly
2. When it comes to emotions, Eastern and Western cultures see things very differently: Study
3. Aromatherapy Falls Short, Study Finds
4. New Study: Aging Baby Boomers Could Overwhelm U.S. Health Care System by 2017, Unless Decisive Action Is Taken
5. Carnegie Mellon study shows just listening to cell phones significantly impairs drivers
6. Southgate Community Schools To Present Studywiz Spark at Michigan Computer Users in Learning (MACUL) Conference
7. WHI follow-up study: Risks of long-term hormone therapy continue to outweigh benefits
8. Diamonds Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers Health and Wealth Needs
9. Study shows cholesterol-lowering power of dietitian visits
10. Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study
11. Genome-wide association study on Parkinsons disease finds public home at NIH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement ... Vice President of North American Capital Sales at HTG Molecular . ... in the commercialization of the HTG EdgeSeq system and associated reagents in North America. ...
(Date:6/24/2016)... FL (PRWEB) , ... June 24, 2016 , ... Finally, ... common after venous procedures, dermaka cream can be incorporated into the post-surgical treatment plans ... minor surgical procedures. , dermaka cream is very effective for bruising and causes ...
(Date:6/24/2016)... AZ (PRWEB) , ... June 24, 2016 , ... SpiritQuest ... the heart of West Sedona, surrounded by famous vortex sites: Cathedral Rock, Airport Mesa, ... from partner properties – the Lodge at Sedona as well as the Sedona Rouge, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
(Date:6/23/2016)... Pa. , June 23, 2016 The ... in an outpatient dialysis facility.  Treatments are usually 3 ... 6 hours per visit, including travel time, equipment preparation ... a patient, but especially grueling for patients who are ... of a skilled nursing and rehabilitation centers for some ...
Breaking Medicine Technology: